Ortho Clinical Diagnostics has had a busy 2020 helping tackle the coronavirus pandemic. Now, the company is joining Wall Street with it's market debut on the Nasdaq. Ortho Clinical Diagnostics CEO Chris Smith joined Cheddar to discuss.